{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:02:09Z","timestamp":1780408929730,"version":"3.54.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Canadian Institutes of Health Research; Kidney Foundation of Canada and Nephcure","award":["PNI-134070"],"award-info":[{"award-number":["PNI-134070"]}]},{"name":"Canadian Institutes of Health Research; Kidney Foundation of Canada and Nephcure","award":["MOP-142271"],"award-info":[{"award-number":["MOP-142271"]}]},{"name":"Canadian Institutes of Health Research; Kidney Foundation of Canada and Nephcure","award":["KFOC-140020"],"award-info":[{"award-number":["KFOC-140020"]}]},{"name":"Canadian Institutes of Health Research; Kidney Foundation of Canada and Nephcure","award":["1038511"],"award-info":[{"award-number":["1038511"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00467-025-06853-8","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:33:20Z","timestamp":1751355200000},"page":"3437-3445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Practice variation in the use of steroid-sparing therapies in childhood steroid-sensitive nephrotic syndrome: results from a prospective cohort study"],"prefix":"10.1007","volume":"40","author":[{"given":"Angie","family":"Aguilar-Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ava","family":"Zardynezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Dart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherry","family":"Mammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulan S.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Geier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Filler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Feber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Tee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Noone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silviu","family":"Grisaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Chanchlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustina","family":"Okpere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2224-448X","authenticated-orcid":false,"given":"Susan","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"6853_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","volume":"392","author":"DG Noone","year":"2018","unstructured":"Noone DG, Iijima K, Parekh R (2018) Idiopathic nephrotic syndrome in children. Lancet 392:61\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(18)30536-1","journal-title":"Lancet"},{"key":"6853_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/20469047.2017.1374003","volume":"37","author":"ML Downie","year":"2017","unstructured":"Downie ML, Gallibois C, Parekh RS, Noone DG (2017) Nephrotic syndrome in infants and children: pathophysiology and management. Paediatr Int Child Health 37:248\u2013258. https:\/\/doi.org\/10.1080\/20469047.2017.1374003","journal-title":"Paediatr Int Child Health"},{"key":"6853_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pcl.2018.08.006","volume":"66","author":"C-S Wang","year":"2019","unstructured":"Wang C-S, Greenbaum LA (2019) Nephrotic Syndrome. Pediatr Clin North Am 66:73\u201385. https:\/\/doi.org\/10.1016\/j.pcl.2018.08.006","journal-title":"Pediatr Clin North Am"},{"key":"6853_CR4","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s004670100021","volume":"16","author":"PA McKinney","year":"2001","unstructured":"McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM (2001) Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol 16:1040\u20131044. https:\/\/doi.org\/10.1007\/s004670100021","journal-title":"Pediatr Nephrol"},{"key":"6853_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fped.2016.00039","volume":"4","author":"R Chanchlani","year":"2016","unstructured":"Chanchlani R, Parekh R (2016) Ethnic differences in childhood nephrotic syndrome. Front Pediatr 4:39. https:\/\/doi.org\/10.3389\/fped.2016.00039","journal-title":"Front Pediatr"},{"key":"6853_CR6","doi-asserted-by":"publisher","unstructured":"(1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98:561\u2013564. https:\/\/doi.org\/10.1016\/s0022-3476(81)80760-3","DOI":"10.1016\/s0022-3476(81)80760-3"},{"issue":"4S","key":"6853_CR7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100(4S):S1\u2013S276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021","journal-title":"Kid Int"},{"key":"6853_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/adc.57.7.544","volume":"57","author":"O Koskimies","year":"1982","unstructured":"Koskimies O, Vilska J, Rapola J, Hallman N (1982) Long-term outcome of primary nephrotic syndrome. Arch Dis Child 57:544\u2013548. https:\/\/doi.org\/10.1136\/adc.57.7.544","journal-title":"Arch Dis Child"},{"key":"6853_CR9","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1681\/ASN.V85769","volume":"8","author":"P Tarshish","year":"1997","unstructured":"Tarshish P, Tobin J, Bernstein J, Edelmann CM (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the international study of kidney disease in children. J Am Soc Nephrol 8:769\u2013776. https:\/\/doi.org\/10.1681\/ASN.V85769","journal-title":"J Am Soc Nephrol"},{"key":"6853_CR10","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1093\/ndt\/gfi274","volume":"21","author":"MD Sinha","year":"2006","unstructured":"Sinha MD, MacLeod R, Rigby E, Clark AGB (2006) Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus. Nephrol Dial Transplant 21:1848\u20131854. https:\/\/doi.org\/10.1093\/ndt\/gfi274","journal-title":"Nephrol Dial Transplant"},{"key":"6853_CR11","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00467-005-1968-8","volume":"20","author":"EM Hodson","year":"2005","unstructured":"Hodson EM, Craig JC, Willis NS (2005) Evidence-based management of steroid-sensitive nephrotic syndrome. Pediatr Nephrol 20:1523\u20131530. https:\/\/doi.org\/10.1007\/s00467-005-1968-8","journal-title":"Pediatr Nephrol"},{"key":"6853_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00467-021-04983-3","volume":"37","author":"F Zotta","year":"2022","unstructured":"Zotta F, Vivarelli M, Emma F (2022) Update on the treatment of steroid-sensitive nephrotic syndrome. Pediatr Nephrol 37:303\u2013314. https:\/\/doi.org\/10.1007\/s00467-021-04983-3","journal-title":"Pediatr Nephrol"},{"key":"6853_CR13","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00467-006-0100-z","volume":"21","author":"BJ Foster","year":"2006","unstructured":"Foster BJ, Shults J, Zemel BS, Leonard MB (2006) Risk factors for corticosteroid- induced obesity in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 21:973\u2013980. https:\/\/doi.org\/10.1007\/s00467-006-0100-z","journal-title":"Pediatr Nephrol"},{"key":"6853_CR14","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00467-003-1142-0","volume":"18","author":"TL Donatti","year":"2003","unstructured":"Donatti TL, Koch VH, Fujimura MD, Okay Y (2003) Growth in steroid-responsive nephrotic syndrome: a study of 85 pediatric patients. Pediatr Nephrol 18:789\u2013795. https:\/\/doi.org\/10.1007\/s00467-003-1142-0","journal-title":"Pediatr Nephrol"},{"key":"6853_CR15","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1056\/NEJMoa040367","volume":"351","author":"MB Leonard","year":"2004","unstructured":"Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA (2004) Long- term, high-dose corticosteroids and bone mineral content in childhood corticosteroid- sensitive nephrotic syndrome. N Engl J Med 351:868\u2013875. https:\/\/doi.org\/10.1056\/NEJMoa040367","journal-title":"N Engl J Med"},{"key":"6853_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1159\/000184944","volume":"48","author":"PV Klepikov","year":"1988","unstructured":"Klepikov PV, Kutyrina MI, Tareyeva E (1988) Steroid-induced hypertension in patients with nephrotic syndrome. Nephron 48:286\u2013290. https:\/\/doi.org\/10.1159\/000184944","journal-title":"Nephron"},{"key":"6853_CR17","first-page":"30","volume":"57","author":"JT Brocklebank","year":"1982","unstructured":"Brocklebank JT, Harcourt RB, Meadow SR (1982) Corticosteroid-induced cataracts in idiopathic nephrotic syndrome. Arch Dis Child 57:30\u201334","journal-title":"Arch Dis Child"},{"key":"6853_CR18","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1093\/ndt\/gfq097","volume":"25","author":"OP Mishra","year":"2010","unstructured":"Mishra OP, Basu B, Upadhyay SK, Prasad R, Schaefer F (2010) Behavioral abnormalities in children with nephrotic syndrome. Nephrol Dial Transplant 25:2537\u20132541. https:\/\/doi.org\/10.1093\/ndt\/gfq097","journal-title":"Nephrol Dial Transplant"},{"key":"6853_CR19","doi-asserted-by":"publisher","first-page":"CD002290","DOI":"10.1002\/14651858.CD002290.pub5","volume":"4","author":"NG Larkins","year":"2020","unstructured":"Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM (2020) Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. Cochrane Database Syst Rev 4:CD002290. https:\/\/doi.org\/10.1002\/14651858.CD002290.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"6853_CR20","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1001\/jama.1988.03720140043031","volume":"259","author":"SA Rivkees","year":"1988","unstructured":"Rivkees SA, Crawford JD (1988) The relationship of gonadal activity and chemotherapy- induced gonadal damage. JAMA 259:2123\u20132125","journal-title":"JAMA"},{"key":"6853_CR21","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/ki.2008.24","volume":"73","author":"K Ishikura","year":"2008","unstructured":"Ishikura K, Ikeda M, Hattori S et al (2008) Effective and safe treatment with cyclosporine in nephrotic children: A prospective, randomized multicenter trial. Kidney Int 73:1167\u20131173. https:\/\/doi.org\/10.1038\/ki.2008.24","journal-title":"Kid Int"},{"key":"6853_CR22","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1046\/j.1523-1755.2002.00303.x","volume":"61","author":"K Ijima","year":"2002","unstructured":"Ijima K, Hamahira K, Tanaka R et al (2002) Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 61:1801\u20131805. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00303.x","journal-title":"Kid Int"},{"key":"6853_CR23","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1111\/ajt.12955","volume":"4","author":"K Budde","year":"2014","unstructured":"Budde K, Bunnapradist S, Grinyo JM, Ciechanowski K, Denny JE, Silva HT, Rostaing L, Envarsus study group (2014) Novel Once-Daily Extended-Release Tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of phase iii, double-blind, randomized trial. Am J Transplant 4:2796\u20132806. https:\/\/doi.org\/10.1111\/ajt.12955","journal-title":"Am J Transplant"},{"key":"6853_CR24","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00228-017-2234-2","volume":"73","author":"S Lichtenberg","year":"2017","unstructured":"Lichtenberg S, Rahamimov R, Green H et al (2017) The incidence of post-transplant cancer among kidney transplant recipients is associated with the level of tacrolimus exposure during the first year after transplantation. Eur J Clin Pharmacol 73:819\u2013826. https:\/\/doi.org\/10.1007\/s00228-017-2234-2","journal-title":"Eur J Clin Pharmacol"},{"key":"6853_CR25","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/01.tp.0000258587.70166.87","volume":"83","author":"TC Jungraithmayr","year":"2017","unstructured":"Jungraithmayr TC, Wiesmayr S, Staskewitz A, German Pediatric Renal Transplantation Study Group et al (2017) Five-year outcome in pediatric patients with mycophenolate mofetil-based renal transplantation. Transplantation 83:900\u2013905. https:\/\/doi.org\/10.1097\/01.tp.0000258587.70166.87","journal-title":"Transplantation"},{"key":"6853_CR26","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1097\/01.tp.0000252683.74584.29","volume":"82","author":"NM Sifontis","year":"2006","unstructured":"Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT (2006) Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82:1698\u20131702. https:\/\/doi.org\/10.1097\/01.tp.0000252683.74584.29","journal-title":"Transplantation"},{"key":"6853_CR27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1212\/01.wnl.0000173031.56429.04","volume":"65","author":"S Vernino","year":"2005","unstructured":"Vernino S, Salomao DR, Habermann TM, O\u2019Neill BP (2005) Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil. Neurology 65:639\u2013641. https:\/\/doi.org\/10.1212\/01.wnl.0000173031.56429.04","journal-title":"Neurology"},{"key":"6853_CR28","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","volume":"384","author":"K Iijima","year":"2014","unstructured":"Iijima K, Sako M, Nozu K, Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group et al (2014) Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 384:1273\u20131281. https:\/\/doi.org\/10.1016\/S0140-6736(14)60541-9","journal-title":"Lancet"},{"key":"6853_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0016-5085(91)90599-g","volume":"100","author":"AS Lok","year":"1991","unstructured":"Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D (1991) Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 100:182\u2013188. https:\/\/doi.org\/10.1016\/0016-5085(91)90599-g","journal-title":"Gastroenterology"},{"key":"6853_CR30","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1001\/archneurol.2011.103","volume":"68","author":"DB Clifford","year":"2011","unstructured":"Clifford DB, Ances B, Costello C et al (2011) Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol 68:1156\u20131164. https:\/\/doi.org\/10.1001\/archneurol.2011.103","journal-title":"Arch Neurol"},{"key":"6853_CR31","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","volume":"38","author":"A Trautmann","year":"2023","unstructured":"Trautmann A, Boyer O, Hodson E, International Pediatric Nephrology Association et al (2023) IPNA clinical practice recommendations for the diagnosis and management of children with steroid\u2010sensitive nephrotic syndrome. Pediatric Nephrol 38:877\u2013919. https:\/\/doi.org\/10.1007\/s00467-022-05739-3","journal-title":"Pediatric Nephrol"},{"key":"6853_CR32","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1007\/s00467-013-2546-0","volume":"28","author":"S Samuel","year":"2013","unstructured":"Samuel S, Morgan CJ, Bitzan M et al (2013) Substantial practice variation exists in the management of childhood nephrotic syndrome. Pediatr Nephrol 28:2289\u20132298. https:\/\/doi.org\/10.1007\/s00467-013-2546-0","journal-title":"Pediatr Nephrol"},{"key":"6853_CR33","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s00467-009-1282-y","volume":"24","author":"N MacHardy","year":"2009","unstructured":"MacHardy N, Miles PV, Massengill SF et al (2009) Management patterns of childhood-onset nephrotic syndrome. Pediatr Nephrol 24:2193\u20132201. https:\/\/doi.org\/10.1007\/s00467-009-1282-y","journal-title":"Pediatr Nephrol"},{"key":"6853_CR34","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s10157-019-01772-z","volume":"23","author":"K Niihata","year":"2019","unstructured":"Niihata K, Nishiwaki H, Kurita N et al (2019) Variations in actual practice patterns and their deviations from the clinical practice guidelines for nephrotic syndrome in Japan: certified nephrologists\u2019 questionnaire survey. Clin Exp Nephrol 23:1288\u20131297. https:\/\/doi.org\/10.1007\/s10157-019-01772-z","journal-title":"Clin Exp Nephrol"},{"key":"6853_CR35","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00431-021-03958-8","volume":"180","author":"AM Schijvens","year":"2021","unstructured":"Schijvens AM, van der Weerd L, van Wijk JAE et al (2021) Practice variations in the management of childhood nephrotic syndrome in the Netherlands. Eur J Pediatr 180:1885\u20131894. https:\/\/doi.org\/10.1007\/s00431-021-03958-8","journal-title":"Eur J Pediatr"},{"key":"6853_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12882-019-1320-3","volume":"20","author":"SM Samuel","year":"2019","unstructured":"Samuel SM, Dart A, Filler G et al (2019) The Canadian childhood nephrotic syndrome (CHILDNEPH) study: report on mid-study feasibility, recruitment and main measures. BMC Nephrol 20:159. https:\/\/doi.org\/10.1186\/s12882-019-1320-3","journal-title":"BMC Nephrol"},{"issue":"1","key":"6853_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2054-3581-1-17","volume":"22","author":"S Samuel","year":"2014","unstructured":"Samuel S, Scott S, Morgan C et al (2014) The Canadian Childhood Nephrotic Syndrome (CHILDNEPH) Project: overview of design and methods. Can J Kidney Health Dis 22:17. https:\/\/doi.org\/10.1186\/2054-3581-1-17","journal-title":"Can J Kidney Health Dis"},{"key":"6853_CR38","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.urolonc.2021.05.017","volume":"39","author":"WH Chou","year":"2021","unstructured":"Chou WH, McGregor B, Schmidt A et al (2021) Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review. Urol Oncol 39:678\u2013685. https:\/\/doi.org\/10.1016\/j.urolonc.2021.05.017","journal-title":"Urol Oncol"},{"key":"6853_CR39","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/s0140-6736(81)92348-5","volume":"1","author":"RS Trompeter","year":"1981","unstructured":"Trompeter RS, Evans PR, Barratt TM (1981) Gonadal function in boys with steroid-responsive nephrotic syndrome treated with cyclophosphamide for short periods. Lancet 1:1177\u20131179. https:\/\/doi.org\/10.1016\/s0140-6736(81)92348-5","journal-title":"Lancet"},{"key":"6853_CR40","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/archdischild-2015-308924","volume":"101","author":"N Larkins","year":"2016","unstructured":"Larkins N, Kim S, Craig J, Hodson E (2016) Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children. Arch Dis Child 101:404\u2013408. https:\/\/doi.org\/10.1136\/archdischild-2015-308924","journal-title":"Arch Dis Child"},{"key":"6853_CR41","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1007\/s00467-018-3970-y","volume":"33","author":"U Querfeld","year":"2018","unstructured":"Querfeld U, Weber LT (2018) Mycophenolate mofetil for sustained remission in nephrotic syndrome. Pediatr Nephrol 33:2253\u20132265. https:\/\/doi.org\/10.1007\/s00467-018-3970-y","journal-title":"Pediatr Nephrol"},{"key":"6853_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10157-016-1266-8","volume":"21","author":"B Basu","year":"2017","unstructured":"Basu B, Babu BG, Mahapatra TKS (2017) Long-term efficacy and safety of common steroid-sparing agents in idiopathic nephrotic children. Clin Exp Nephrol 21:143\u2013151. https:\/\/doi.org\/10.1007\/s10157-016-1266-8","journal-title":"Clin Exp Nephrol"},{"key":"6853_CR43","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00467-024-06605-0","volume":"40","author":"C Robinson","year":"2025","unstructured":"Robinson C, Aman N, Banh T et al (2025) Prolonged remission after cyclophosphamide or tacrolimus treatment in childhood nephrotic syndrome: a prospective cohort study. Pediatr Nephrol 40:1625\u20131634. https:\/\/doi.org\/10.1007\/s00467-024-06605-0","journal-title":"Pediatr Nephrol"},{"key":"6853_CR44","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamapediatrics.2018.1323","volume":"172","author":"B Basu","year":"2018","unstructured":"Basu B, Sander A, Birendranath R et al (2018) Efficacy of rituximab vs tacrolimus in pediatric corticosteroid-dependent nephrotic syndrome: a randomized clinical trial. JAMA Pediatr 172:757\u2013764. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.1323","journal-title":"JAMA Pediatr"},{"key":"6853_CR45","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijpam.2017.03.002","volume":"4","author":"K Alsaran","year":"2017","unstructured":"Alsaran K, Mirza K, Al-Talhi A, Al-Kanani E (2017) Experience with second line drugs in frequently relapsing and steroid dependent childhood nephrotic syndrome in a large Saudi center. Int J Pediatr Adolesc Med 4:66\u201370. https:\/\/doi.org\/10.1016\/j.ijpam.2017.03.002","journal-title":"Int J Pediatr Adolesc Med"},{"key":"6853_CR46","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3390\/medicina59030601","volume":"59","author":"K Nagai","year":"2023","unstructured":"Nagai K (2023) Immunosuppressive agent options for primary nephrotic syndrome: a review of network meta-analyses and cost-effectiveness analysis. Medicina (Kaunas) 59:601. https:\/\/doi.org\/10.3390\/medicina59030601","journal-title":"Medicina (Kaunas)"},{"key":"6853_CR47","unstructured":"Canadian Medical Association (2024) How is healthcare funded in Canada? https:\/\/www.cma.ca\/how-health-care-funded-canada#:~:text=More%20than%2070%25%20of%20health,since%20Medicare%20was%20first%20established. Accessed 19 Sept 2024"},{"key":"6853_CR48","doi-asserted-by":"publisher","first-page":"205435812210799","DOI":"10.1177\/20543581221079959","volume":"9","author":"C Meeuwisse","year":"2022","unstructured":"Meeuwisse C, Morgan CJ, Samuel S, Todd A, Rodriguez-Lopez S (2022) Rituximab use for the treatment of childhood nephrotic syndrome by canadian pediatric nephrologists: a national survey. Can J Kidney Health Dis 9:20543581221079959. https:\/\/doi.org\/10.1177\/20543581221079959","journal-title":"Can J Kidney Health Dis"},{"key":"6853_CR49","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.socscimed.2005.07.001","volume":"62","author":"D Mclyntyre","year":"2006","unstructured":"Mclyntyre D, Thede M, Dalgren G, Whitehead M (2006) What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts? Soc Sci Med 62:858\u2013865. https:\/\/doi.org\/10.1016\/j.socscimed.2005.07.001","journal-title":"Soc Sci Med"},{"key":"6853_CR50","doi-asserted-by":"publisher","first-page":"151311","DOI":"10.1016\/j.semnephrol.2023.151311","volume":"42","author":"AD Ademola","year":"2022","unstructured":"Ademola AD, Asinobi AO, Alao MA, Olowu WA (2022) Childhood nephrotic syndrome in africa: epidemiology, treatment trends, and outcomes. Semin Nephrol 42:151311. https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151311","journal-title":"Semin Nephrol"},{"key":"6853_CR51","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/BF00853590","volume":"1","author":"P Niaudet","year":"1987","unstructured":"Niaudet P, Habib R, Tete MJ, Hinglais N, Broyer M (1987) Cyclosporin in the treatment of idiopathic nephrotic syndrome in children. Pediatr Nephrol 1:566\u2013573. https:\/\/doi.org\/10.1007\/BF00853590","journal-title":"Pediatr Nephrol"},{"key":"6853_CR52","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/ki.1993.194","volume":"43","author":"C Ponticelli","year":"1993","unstructured":"Ponticelli C, Rizzoni G, Edefonti A et al (1993) A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43:1377\u20131384. https:\/\/doi.org\/10.1038\/ki.1993.194","journal-title":"Kidney Int"},{"key":"6853_CR53","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1046\/j.1523-1755.1999.00778.x","volume":"56","author":"DC Cattran","year":"1999","unstructured":"Cattran DC, Appel GB, Hebert LA et al (1999) A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America nephrotic syndrome study group. Kidney Int 56:2220\u20132226. https:\/\/doi.org\/10.1046\/j.1523-1755.1999.00778.x","journal-title":"Kidney Int"},{"key":"6853_CR54","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1053\/j.ajkd.2008.11.033","volume":"53","author":"S Choudhry","year":"2009","unstructured":"Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A (2009) Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. Am J Kid Dis 53:760\u2013769. https:\/\/doi.org\/10.1053\/j.ajkd.2008.11.033","journal-title":"Am J Kid Dis"},{"key":"6853_CR55","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(98)07493-5","volume":"353","author":"MD Denton","year":"1999","unstructured":"Denton MD, Magee CC, Sayegh MH (1999) Immunosuppressive strategies in transplantation. Lancet 353:1083\u20131091. https:\/\/doi.org\/10.1016\/S0140-6736(98)07493-5","journal-title":"Lancet"},{"key":"6853_CR56","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/jcm8060860","volume":"8","author":"AK M\u00fchlig","year":"2019","unstructured":"M\u00fchlig AK, Lee JY, Kemper MJ et al (2019) Levamisole in children with idiopathic nephrotic syndrome: clinical efficacy and pathophysiological aspects. J Clin Med 8:860. https:\/\/doi.org\/10.3390\/jcm8060860","journal-title":"J Clin Med"},{"key":"6853_CR57","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.kint.2018.08.039","volume":"95","author":"A Sinha","year":"2019","unstructured":"Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A (2019) Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial. Kidney Int 95:210\u2013218. https:\/\/doi.org\/10.1016\/j.kint.2018.08.039","journal-title":"Kidney Int"},{"key":"6853_CR58","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.semarthrit.2018.07.010","volume":"48","author":"A Dartevel","year":"2019","unstructured":"Dartevel A, Chaigne B, Moachon L et al (2019) Levamisole-induced vasculopathy: a systematic review. Semin Arthritis Rheum 48:921\u2013926. https:\/\/doi.org\/10.1016\/j.semarthrit.2018.07.010","journal-title":"Semin Arthritis Rheum"},{"key":"6853_CR59","doi-asserted-by":"publisher","first-page":"i106","DOI":"10.1093\/ndt\/gfw309","volume":"32","author":"MA Hladunewich","year":"2017","unstructured":"Hladunewich MA, Beanlands H, Herreshoff E et al (2017) Provider perspectives on treatment decision-making in nephrotic syndrome. Nephrol Dial Transplant 32:i106\u2013i114. https:\/\/doi.org\/10.1093\/ndt\/gfw309","journal-title":"Nephrol Dial Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06853-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06853-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06853-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:11:53Z","timestamp":1759234313000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06853-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["6853"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06853-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5723983\/v1","asserted-by":"object"}]},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}